A detailed history of Octagon Capital Advisors LP transactions in Terns Pharmaceuticals, Inc. stock. As of the latest transaction made, Octagon Capital Advisors LP holds 1,364,400 shares of TERN stock, worth $9.47 Million. This represents 2.15% of its overall portfolio holdings.

Number of Shares
1,364,400
Previous 625,000 118.3%
Holding current value
$9.47 Million
Previous $4.1 Million 126.67%
% of portfolio
2.15%
Previous 0.64%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$4.54 - $8.2 $3.36 Million - $6.06 Million
739,400 Added 118.3%
1,364,400 $9.29 Million
Q1 2024

May 15, 2024

BUY
$4.86 - $8.19 $3.04 Million - $5.12 Million
625,000 New
625,000 $4.1 Million

Others Institutions Holding TERN

About Terns Pharmaceuticals, Inc.


  • Ticker TERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,613,800
  • Market Cap $261M
  • Description
  • Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and obesity. The company develops TERN-101, a liver-distributed and non-bile acid farnesoid X receptor agonist, which is in Phase IIa clinical t...
More about TERN
Track This Portfolio

Track Octagon Capital Advisors LP Portfolio

Follow Octagon Capital Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Octagon Capital Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Octagon Capital Advisors LP with notifications on news.